Angiotensin II type 1 receptor signals through Raf-1 by a protein kinase C-dependent, Ras-independent mechanism

Molecular Pharmacology

Volumn 50, Issue 3, 1996, Pages 522-528

  Arai, Hidenori ^a   Escobedo, Jaime A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; CALCIUM ION; MITOGEN ACTIVATED PROTEIN KINASE; PERTUSSIS TOXIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN C FOS; PROTEIN KINASE C; RAF PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHO CELL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME MECHANISM; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION;

ADENYLATE CYCLASE; ADENYLATE CYCLASE TOXIN; ANIMALS; AORTA; BETA-GALACTOSIDASE; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CALCIUM; CHO CELLS; CLONING, MOLECULAR; CRICETINAE; ENZYME ACTIVATION; FORSKOLIN; GENE EXPRESSION REGULATION; GENES, FOS; GENES, REPORTER; HUMANS; KINETICS; LUCIFERASES; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MUSCLE, SMOOTH, VASCULAR; PERTUSSIS TOXIN; PROTEIN KINASE C; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-RAF; PROTO-ONCOGENE PROTEINS P21(RAS); RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE; TRANSFECTION; VIRULENCE FACTORS, BORDETELLA;

EID: 0029786877     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Gibbons, G. H., and V. J. Dzau. Angiotensin converting enzyme inhibition and vascular hypertrophy in hypertension. Cardiovasc. Drugs Ther. 4:237-242 (1990).
2. Sasaki, K., Y. Yamano, S. Bardhan, N. Iwai, J. J. Murray, M. Hasegawa, Y. Matsuda, and T. Inagami. Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor. Nature (Lond.) 351:230-233 (1991).
3. Murphy, T. J., R. W. Alexander, K. K. Griendling, M. S.Runge, and K. E. Bernstein. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature (Lond.) 351:233-236 (1991).
4. Iwai, N., and T. Inagami. Identification of two subtypes in the rat type I angiotensin II receptor. FEBS Lett. 298:257-260 (1992).
5. Ohnishi, J., M. Ishido, T. Shibata, T. Inagami, K. Murakami, and H. Miyazaki. The rat angiotensin II AT1A receptor couples with three different signal transduction pathways. Biochem. Biophys. Res. Commun. 186: 1094-1101 (1992).
6. Griendling, K. K., B. Lassegue, and R. W. Alexander. The vascular angiotensin (AT1) receptor. Thromb. Haemost. 70:188-192 (1993).
7. Schorb, W., G. W. Booz, D. E. Dostal, K. M. Conrad, K. C. Chang, and K. M. Baker. Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts. Circ. Res. 72:1245-1254 (1993).
8. Molloy, C. J., D. S. Taylor, and H. Weber. Angiotensin II stimulation of rapid protein tyrosine phosphorylation and protein kinase activation in rat aortic smooth muscle cells. J. Biol. Chem. 268:7338-7345 (1993).
9. Butcher, R. D., C. Schollmann, and D. Marme. Angiotensin II mediates intracellular signalling in vascular smooth muscle cells by activation of tyrosine-specific protein kinases and c-raf-1. Biochem. Biophys. Res. Commun. 196:1280-1287 (1993).
10. App, H., R. Hazan, A. Zilberstein, A. Ullrich, J. Schlessinger, and U. Rapp. Epidermal growth factor (EGF) stimulates association and kinase activity of Raf-1 with the EGF receptor. Mol. Cell Biol. 11:913-919 (1991).
11. Naftilan, A. J., R. E. Pratt, and V. J. Dzau. Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J. Clin. Invest, 83:1419-1424 (1989).
12. 2+ mobilization and protein kinase C activation. J. Biol. Chem. 264:526-530 (1989).
13. Naftilan, A. J., G. K. Gilliland, C. S. Eldridge, and A. S. Kraft. Induction of the proto-oncogene c-jun by angiotensin II. Mol. Cell Biol. 10:5536-5540 (1990).
14. Kolch, W., G. Heidecker, G. Kochs, R. Hummel, H. Vahidi, H. Mischak, G. Finkenzeller, D. Marme, and U. R. Rapp. Protein kinase C alpha activates RAF-1 by direct phosphorylation. Nature (Lond.) 364:249-252 (1993).
15. Sozeri, O., K. Vollmer, M. Liyanage, D. Frith, G. Kour, G. E. D. Mark, and S. Stabel. Activation of the c-Raf protein kinase by protein kinase C phosphorylation. Oncogene 7:2259-2262 (1992).
16. Crespo, P., N. Xu, J. L. Daniotti, J. Troppmair, U. R. Rapp, and J. S. Gutkind. Signaling through transforming G protein-coupled receptors in NIH 3T3 cells involves c-Raf activation: evidence for a protein kinase C-independent pathway. J. Biol. Chem. 269:21103-21109 (1994).
17. Howe, L. R., and C. J. Marshall. Lysophosphatidic acid stimulates mitogen-activated protein kinase activation via a G-protein-coupled pathway requiring p21ras and p74raf-1. J. Biol. Chem. 268:20717-20720 (1993).
18. Alblas, J., E. J. van Corven, P. L. Hordijk, G. Milligan, and W. H. Moolenaar. Gi-mediated activation of the p21ras-mitogen-activated protein kinase pathway by alpha 2-adrenergic receptors expressed in fibroblasts. J. Biol. Chem. 268:22235-22238 (1993).
19. van Corven, E. J., P. L. Hordijk, R. H. Medema, J. L. Bos, and W. H. Moolenaar. Pertussis toxin-sensitive activation of p21ras by G protein-coupled receptor agonists in fibroblasts. Proc. Natl. Acad. Sci. USA 90: 1257-1261 (1993).
20. Lange-Carter, C. A., C. M. Pleiman, A. M. Gardner, K. J. Blumer, and G. L. Johnson. A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf. Science (Washington D. C.) 260:315-319 (1993).
21. Minden, A., A. Lin, M. McMahon, C. Lange-Carter, B. Derijard, R. J. Davis, G. L. Johnson, and M. Karin. Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science (Washington D. C.) 266:1719-1723 (1994).
22. Sadoshima, J., and S. Izumo. Signal transduction pathways of angiotensin II-induced c-fos gene expression in cardiac myocytes in vitro: roles of phospholipid-derived second messengers. Circ. Res. 73:424-438 (1993).
23. Kikuchi, A., and L. T. Williams. The post-translational modification of ras p21 is important for Raf-1 activation. J. Biol. Chem. 269:20054-20059 (1994).
24. Wong, Y. H., A. Federman, A. M. Pace, I. Zachary, T. Evans, J. Pouyssegur, and H. R. Bourne. Mutant alpha subunits of Gi2 inhibit cyclic AMP accumulation. Nature (Lond.) 351:63-65 (1991).
25. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:3440-3450 (1985).
26. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.) 227:680-685 (1970).
27. Faure, M., T. A. Voyno-Yasenetskaya, and H. R. Bourne. cAMP and beta gamma subunits of heterotrimeric G proteins stimulate the mitogen-activated protein kinase pathway in COS-7 cells. J. Biol. Chem. 269:7851-7854 (1994).
28. Kubalak, S. W., and J. G. Webb. Angiotensin II enhancement of hormonestimulated cAMP formation in cultured vascular smooth muscle cells. Am. J. Physiol. 264:H86-H96 (1993).
29. Langlois, D., M. Begeot, M. C. Berthelon, C. Jaillard, and J. M. Saez. Angiotensin II potentiates agonist-induced 3′:5′-cyclic adenosine monophosphate production by cultured bovine adrenal cells through protein kinase C and calmodulin pathways. Endocrinology 131:2189-2195 (1992).
30. Wheeler, M. B., and J. D. Veldhuis. Facilitative actions of the protein kinase-C effector system on hormonally stimulated adenosine 3′,5′-monophosphate production by swine luteal cells. Endocrinology 125:2414-2420 (1989).
31. Chen, W. S., C. S. Lazar, M. Poenie, R. Y. Tsien, G. N. Gill, and M. G. Rosenfeld. Requirement for intrinsic protein tyrosine kinase in the immediate and late actions of the EGF receptor. Nature (Lond.) 328:820-823 (1987).
32. Dent, P., W. Haser, T. A. Haystead, L. A. Vincent,T. M. Roberts, and T. W. Sturgill. Activation of mitogen-activated protein kinase kinase by v-Raf in NIH 3T3 cells and in vitro. Science (Washington D. C.) 257:1404-1407 (1992).
33. Crews, C. M., A. Alessandrini, and R. L. Erikson. The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product. Science (Washington D. C.) 258:478-480 (1992).
34. Kyriakis, J. M., H. App, X. F. Zhang, P. Banerjee, D. L. Brautigan, U. R. Rapp, and J. Avruch. Raf-1 activates MAP kinase-kinase. Nature (Lond.) 358:417-421 (1992).
35. Morrison, D. K., D. R. Kaplan, J. A. Escobedo, U. R. Rapp, T. M. Roberts, and L. T. Williams. Direct activation of the serine/threonine kinase activity of Raf-1 through tyrosine phosphorylation by the PDGF beta-receptor. Cell 58:649-657 (1989).
36. Jaiswal, R. K., S. A. Moodie, A. Wolfman, and G. E. Landreth. The mitogen-activated protein kinase cascade is activated by B-Raf in response to nerve growth factor through interaction with p21ras. Mol. Cell Biol. 14:6944-6953 (1994).
37. Nishizuka, Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science (Washington D. C.) 258:607-614 (1992).
38. Hirai, S., Y. Izumi, K. Higa, K. Kaibuchi, K. Mizuno, S. Osada, K. Suzuki, and S. Ohno. Ras-dependent signal transduction is indispensable but not sufficient for the activation of AP1/Jun by PKC delta. EMBO J. 13:2331-2340 (1994).
39. Escobedo, J. A., P. J. Barr, and L. T. Williams. Role of tyrosine kinase and membrane-spanning domains in signal transduction by the platelet-derived growth factor receptor. Mol. Cell Biol. 8:5126-5131 (1988).
40. de Vries-Smits, A. M., B. M. Burgering, S. J. Leevers, C. J. Marshall, and J. L. Bos. Involvement of p21ras in activation of extracellular signal-regulated kinase 2. Nature (Lond.) 357:602-604 (1992).
41. Wood, K. W., C. Sarnecki, T. M. Roberts, and J. Blenis. ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase, Raf-1, and RSK. Cell 68:1041-1050 (1992).
42. Marquardt, B., D. Frith, and S. Stabel. Signalling from TPA to MAP kinase requires protein kinase C, raf and MEK: reconstitution of the signalling pathway in vitro. Oncogene 9:3213-3218 (1994).
43. 2+ dependent signaling. Circ. Res. 76:1-15 (1995)
44. Rozengurt, E. Cyclic AMP:a growth-promoting signal for mouse 3T3 cells. Adv. Cyclic Nucleotide Res. 14:429-442 (1981).
45. Loesberg, C., R. Van Wijk, J. Zandbergen, W. G. Van Aken, J. A. Van Mourik, and P. G. De Groot. Cell cycle-dependent inhibition of human vascular smooth muscle cell proliferation by prostaglandin E1. Exp. Cell Res. 160:117-125 (1985).
46. Giasson, E., and S. Meloche. Role of p70 S6 protein kinase in angiotensin II-induced protein synthesis in vascular smooth muscle cells. J. Biol. Chem. 270:5225-5231 (1995).